NEUROCRINE BIOSCIENCES INC Shares Outstanding (Cover Page)
NEUROCRINE BIOSCIENCES INC (NBIX) had Shares Outstanding (Cover Page) of 101.65 million shares as of 2026-07-22, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-31
- 2026-07-22: Entity Common Stock, Shares Outstanding 101.65M shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 100.55M shares.
- 2026-02-04: Entity Common Stock, Shares Outstanding 100.36M shares.
- 2025-10-21: Entity Common Stock, Shares Outstanding 99.71M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-22 | 101.65M shares 10-Q · filed 2026-07-31 |
| 2026-04-28 | 100.55M shares 10-Q · filed 2026-05-05 |
| 2026-02-04 | 100.36M shares 10-K · filed 2026-02-11 |
| 2025-10-21 | 99.71M shares 10-Q · filed 2025-10-28 |
| 2025-07-24 | 99.18M shares 10-Q · filed 2025-07-30 |
| 2025-04-30 | 98.97M shares 10-Q · filed 2025-05-05 |
| 2025-02-05 | 99.70M shares 10-K · filed 2025-02-10 |
| 2024-10-24 | 101.25M shares 10-Q · filed 2024-10-30 |
| 2024-07-26 | 100.98M shares 10-Q · filed 2024-08-01 |
| 2024-04-25 | 100.64M shares 10-Q · filed 2024-05-01 |
| 2024-02-05 | 99.51M shares 10-K · filed 2024-02-09 |
| 2023-10-25 | 98.25M shares 10-Q · filed 2023-10-31 |
| 2023-07-26 | 97.65M shares 10-Q · filed 2023-08-01 |
| 2023-04-26 | 97.57M shares 10-Q · filed 2023-05-03 |
| 2023-01-31 | 96.59M shares 10-K · filed 2023-02-09 |
| 2022-10-28 | 96.13M shares 10-Q · filed 2022-11-01 |
| 2022-07-28 | 95.64M shares 10-Q · filed 2022-08-04 |
| 2022-04-28 | 95.58M shares 10-Q · filed 2022-05-04 |
| 2022-02-07 | 95.24M shares 10-K · filed 2022-02-11 |
| 2021-10-27 | 94.87M shares 10-Q · filed 2021-11-01 |
| 2021-07-28 | 94.65M shares 10-Q · filed 2021-08-03 |
| 2021-04-29 | 94.55M shares 10-Q · filed 2021-05-05 |
| 2021-01-29 | 93.94M shares 10-K · filed 2021-02-05 |
| 2020-11-04 | 93.43M shares 10-Q · filed 2020-11-09 |
| 2020-07-28 | 93.25M shares 10-Q · filed 2020-08-03 |
| 2020-04-30 | 92.87M shares 10-Q · filed 2020-05-06 |
| 2020-01-31 | 92.29M shares 10-K · filed 2020-02-07 |
| 2019-10-29 | 92.09M shares 10-Q · filed 2019-11-04 |
| 2019-07-24 | 91.58M shares 10-Q · filed 2019-07-29 |
| 2019-04-24 | 91.29M shares 10-Q · filed 2019-04-29 |
| 2019-02-01 | 90.82M shares 10-K · filed 2019-02-08 |
| 2018-10-30 | 90.68M shares 10-Q · filed 2018-11-05 |
| 2018-07-25 | 90.47M shares 10-Q · filed 2018-07-31 |
| 2018-04-25 | 89.90M shares 10-Q · filed 2018-04-30 |
| 2018-02-02 | 89.27M shares 10-K · filed 2018-02-13 |
| 2017-10-27 | 88.49M shares 10-Q · filed 2017-11-01 |
| 2017-07-27 | 88.22M shares 10-Q · filed 2017-08-03 |
| 2017-05-03 | 88.07M shares 10-Q · filed 2017-05-09 |
| 2017-02-01 | 87.11M shares 10-K · filed 2017-02-14 |
| 2016-10-27 | 86.87M shares 10-Q · filed 2016-11-02 |
| 2016-07-28 | 86.75M shares 10-Q · filed 2016-08-03 |
| 2016-04-29 | 86.66M shares 10-Q · filed 2016-05-05 |
| 2016-02-01 | 86.45M shares 10-K · filed 2016-02-11 |
| 2015-10-23 | 86.20M shares 10-Q · filed 2015-10-29 |
| 2015-07-24 | 85.87M shares 10-Q · filed 2015-07-29 |
| 2015-04-24 | 85.42M shares 10-Q · filed 2015-04-30 |
| 2015-01-26 | 77.16M shares 10-K · filed 2015-02-09 |
| 2014-10-27 | 76.01M shares 10-Q · filed 2014-11-04 |
| 2014-07-31 | 75.92M shares 10-Q · filed 2014-08-06 |
| 2014-04-25 | 75.86M shares 10-Q · filed 2014-05-01 |
| 2014-01-24 | 67.79M shares 10-K · filed 2014-02-11 |
| 2013-10-23 | 67.34M shares 10-Q · filed 2013-10-29 |
| 2013-07-19 | 67.06M shares 10-Q · filed 2013-07-26 |
| 2013-04-26 | 66.73M shares 10-Q · filed 2013-05-02 |
| 2013-01-31 | 66.51M shares 10-K · filed 2013-02-08 |
| 2012-10-25 | 66.38M shares 10-Q · filed 2012-10-31 |
| 2012-07-24 | 66.33M shares 10-Q · filed 2012-07-31 |
| 2012-04-27 | 66.31M shares 10-Q · filed 2012-05-02 |
| 2012-01-31 | 66.24M shares 10-K · filed 2012-02-09 |
| 2011-10-26 | 55.26M shares 10-Q · filed 2011-10-31 |
| 2011-07-22 | 55.24M shares 10-Q · filed 2011-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |